Disturbed circadian blood pressure rhythm and C-reactive protein in essential hypertension

Journal of Human Hypertension

Volumn 22, Issue 7, 2008, Pages 501-508

  Tsioufis, C ^a   Syrseloudis, D ^b   Dimitriadis, K ^a   Thomopoulos, C ^a   Tsiachris, D ^a   Pavlidis, P ^b   Selima, M ^a   Kallikazaros, I ^b   Stefanadis, C ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b HIPPOKRATION HOSPITAL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN;

ADULT; AGED; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE MONITORING; BLOOD SAMPLING; BODY MASS; CIGARETTE SMOKING; CIRCADIAN RHYTHM; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE DURATION; ECHOCARDIOGRAPHY; ESSENTIAL HYPERTENSION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE REGRESSION; NIGHT; PREDICTION; PROTEIN ANALYSIS; PULSE PRESSURE; SYSTOLIC BLOOD PRESSURE; VENOUS BLOOD; WAIST HIP RATIO;

ADULT; BIOLOGICAL MARKERS; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; C-REACTIVE PROTEIN; CIRCADIAN RHYTHM; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED;

EID: 45849085718     PISSN: 09509240     EISSN: 14765527     Source Type: Journal    
DOI: 10.1038/jhh.2008.20     Document Type: Article

References (21)

1. Hackam DG, Anand SS. Emerging risk factors for atherosclerotic vascular disease: A critical review of the evidence. J Am Med Assoc 2003; 290: 932-940.
2. Ridker PM, Hennekens CH, Buring JE, Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 2000; 342: 836-843.
3. Sesso HD, Buring JE, Rifai N, Blake G, Gaziano M, Ridker P. C- Reactive protein and the risk of developing hypertension. JAMA 2003; 290 2945-2951.
4. Virdis A, Schiffrin EL. Vascular inflammation: A role in vascular disease in hypertension? Curr Opin Nephrol Hypertens 2003; 12 181-187.
5. Chou H, Gaillard C, Van Der Meijden B, Dijstelbloem H, Kraaijenhagen R, Van Leenen D et al. Broadly altered gene expression in blood leukocytes in essential hypertension is absent during treatment. Hypertension 2004; 43: 947-995.
6. Tsioufis C, Stougiannos P, Kakkavas A, Toutouza M, Mariolis A, Vlasseros I et al. Relation of left ventricular concentric remodeling to levels of C-reactive protein and serum amyloid A in patients with essential hypertension. Am J Cardiol 2005; 2: 252-256.
7. Tsioufis C, Dimitriadis K, Chatzis D, Vasiliadou C, Tousoulis D, Papademetriou V et al. Relation of microalbuminuria to adiponectin and augmented C-reactive protein levels in men with essential hypertension. Am J Cardiol 2005; 96: 946-951.
8. Verdecchia P. Prognostic value of ambulatory blood pressure, current evidence and clinical implications. Hypertension 2000; 35: 844-851.
9. Tsioufis C, Stefanadis C, Antoniadis D, Kallikazaros I, Zambaras P, Pitsavos C et al. Absence of any significant effects of circadian blood pressure variations on carotid artery elastic properties in essential hypertensive subjects. J Hum Hypertens 2000; 14: 813-818.
10. Verdecchia P, Schillaci G, Guerrieri M, Gatteschi C, Benemio G, Boldrini F et al. Circadian blood pressure changes and left ventricular hypertrophy in essential hypertension. Circulation 1990; 81: 528-536.
11. Metoki H, Ohkubo T, Kikuya M, Asayama K, Obara T, Hashimoto J et al Prognostic significance for stroke of a morning pressor surge and a nocturnal blood pressure decline: The Ohasama Study. J Hypertens 2006; 47: 149-154.
12. Pearson TA, Mensah GA, Alexander RW, Anderson. JL, Cannon RO, Criqui M et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centres for Disease Control and Prevention and the American Heart Association. Circulation 2003; 107: 499-511.
13. Gottdiener JS, Bednarz J, Devereux R, Gardin J, Klein A, Manning WJ et al. American society of echocardiography: Recommendations for use of echocardiography in clinical trials; a report from the American society of echocardiography. J Am Soc Echocardiogr 2004; 17: 1086-1119.
14. Verdecchia P, Schillaci G, Borgioni C, Ciucci A, Sacchi N, Battistelli M et al. Gender, daynight blood pressure changes and left ventricular mass in essential hypertension. Dippers and Peakers. Am J Hypertens 1995; 8: 193-196.
15. Gorostidi M, Sobrino J, Segura J, Sierra C, de la Sierra A, Hernandez Del Rey R et al. Ambulatory blood pressure monitoring in hypertensive patients with high cardiovascular risk: A cross-sectional analysis of a 20 000-patient database in Spain. J Hypertens 2007; 25: 977-984.
16. Maeda K, Yasunari K, Watanabe T, Nakamura M. Oxidative stress by peripheral blood mononuclear cells is increased in hypertensives with an extreme-dipper pattern and/or morning surge in blood pressure. Hypertens Res 2005; 28: 755-761.
17. Von Kanel R, Jain S, Mills PJ, Nelesen RA, Adler KA, Hong S et al. Relation of nocturnal blood pressure dipping to cellular adhesion, inflammation and hemostasis. J Hypertens 2004; 22: 2087-2093.
18. Schillaci G, Pirro M, Gemelli F, Pasqualini L, Vaudo G, Marchesi S et al. Increased C-reactive protein concentrations in never-treated hypertension: The role of systolic and pulse pressures. J Hypertens 2003; 21: 1841-1846.
19. Abramson J, Weintraub W, Vaccarino V. Association between pulse pressure and Greactive protein among apparently healthy US adults. Hypertension 2002; 39: 197-202.
20. Tsioufis C, Antoniadis D, Stefanadis C, Tzioumis K, Pitsavos C, Kallikazaros I et al. Relationships between new risk factors and circadian blood pressure variation in untreated subjects with essential hypertension. Am J Hypertens 2002; 15: 600-604.
21. Gilardini L, Parati G, Sartorio A, Mazzilli G, Pontiggia B, Invitti C. Sympathoadrenergic and metabolic factors re involved in ambulatory blood pressure rise in childhood obesity. J Hum Hypertens 2008; 22 75-82.